Medical/Pharmaceuticals

European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

SHANGHAI, April 29, 2026 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar ...

2026-04-29 18:08 3267

INTCO Medical Reports 2025 Results with Resilient Growth, Revenue Reaches Four-Year High as Industry Rebalances

ZIBO, China, April 29, 2026 /PRNewswire/ -- INTCO Medical ("INTCO" or "the Company"), a leading global manufacturer of disposable gloves, reported its 2025 annual results, with revenue reaching RMB 9.93 billion (approximately US$1.46 billion), up 4.23% year over y...

2026-04-29 17:07 4763

State Grid Changzhou Power Pioneers Drone-Based Ultraviolet Imaging Technology for Precision Power Line Fault Detection

CHANGZHOU, China, April 29, 2026 /PRNewswire/ -- State Grid Changzhou Power Supply Company has deployed drone-based ultraviolet (UV) imaging technology for the first time to enable precision inspection of distribution lines in Liyang, Changzhou. The new technical solution supports early detection...

2026-04-29 17:04 3568

WHX Bangkok and Medtec Southeast Asia 2026 to Position Thailand as the Gateway to ASEAN's Medical Market

BANGKOK, April 29, 2026 /PRNewswire/ -- From 8 to 10 July, Informa Markets will take the global stage, uniting over 950 exhibitors at International Healthcare Week and reinforcing Thailand's leadership in healthcare and medical manufacturing. The event will feature two major co-located exhibit...

2026-04-29 14:02 3898

ABC Impact Releases 2025 Impact Review

SINGAPORE, April 29, 2026 /PRNewswire/ -- ABC Impact, the Singapore-based Asia-focused impact investment firm, has published its 2025 Impact Review, available atwww.abcimpact.com.sg . The review covers the firm's investment and impact activity across its two funds ov...

2026-04-29 11:00 2896

Alma Unveils Longevity Approach at Alma Academy, Advancing Long-Term Skin Performance

CAESAREA, Israel, April 29, 2026 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in medical aesthetic solutions, unveiled its longevity strategy at its global Alma Academy, outlining its shift toward a continuous care model and a new long-term growth a...

2026-04-29 09:30 3423

The Benefits of Prostate Cancer Screening Outweigh the Harms, According to New Patient Guidelines From NCCN

Free, comprehensive guidebook shows how prostate cancer screening has largely deemphasized invasive testing in order to avoid unnecessary procedures and treatment while at the same time saving lives. PLYMOUTH MEETING, Pa., April 28, 2026 /PRNewswire/ -- The National Comprehensive Cancer Network®...

2026-04-28 22:04 4375

Echosens Appoints Romain Baujard as Group Chief Executive Officer

Company to accelerate its mission to make liver health a vital sign in cardiometabolic care; appointment follows retirement of current Group CEO Dominique Legros PARIS, April 28, 2026 /PRNewswire/ -- Echosens , a global diagnostic company specializing in non-invasive m...

2026-04-28 20:00 2387

Kuching to Host Malaysia's First CIFA Regional Symposium

KUCHING, Malaysia, April 28, 2026 /PRNewswire/ -- Malaysia has been selected to host the Consortium of Institutes on Family in the Asian Region (CIFA) Regional Symposium 2026, co-organised by the National Coalition for Mental Wellbeing (NCMW) Malaysia and CIFA Hong Kong, with Kuching making histor...

2026-04-28 16:52 3598

3Shape Receives FDA 510(k) Clearance for 3Shape Dx Software

COPENHAGEN, Denmark, April 28, 2026 /PRNewswire/ -- 3Shape today announced that the U.S. Food and Drug Administration (FDA) has granted FDA clearance for its Dx Software following a review completed on April 10. 2026. The 510(k) Premarket Notification allows Dx (R1) software to be commercially a...

2026-04-28 15:43 3237

HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California

SINGAPORE, April 28, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnership network in the United States with the addition of two new hepatology and gastroenterology centers...

2026-04-28 15:30 4666

Australian company unlocks a new era for women's health globally with an innovative delivery system for Female testosterone in women with low libido

* Massive unmet need for Hypoactive Sexual Desire Disorder treatments addressed by new Female Testosterone product * Phase I and II clinical trials completed. Phase III to be done in co-development with global partners. * Unique, Australian developed unique Patchless Patch™ delivery technolo...

2026-04-28 14:25 2957

BLINDED ASSESSMENT OF ACTION3 STATISTICAL ASSUMPTIONS COMPLETE

Key Highlights: * An external statistical blinded review of ACTION3 data has achieved its objective by confirming that the study remains appropriately statistically powered (>90%) to demonstrate a treatment effect for the primary study endpoint of proteinuria; meaning that if DMX-200 continues...

2026-04-28 10:17 2867

Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan

TOKYO, April 28, 2026 /PRNewswire/ -- Cordis, a global leader in interventional cardiovascular technologies, today announces the launch and availability of the SELUTION SLR™ PTA Drug-Eluting Balloon (DEB)1 for use in Japan. SELUTION SLR™ DEB is designed to deliver sirolimus in a controlled, susta...

2026-04-28 09:00 4298

Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach

MELBOURNE, Australia and INDIANAPOLIS, April 28, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces an educational webinar exploring the evolution of PSMA[1]-targeted radionuclide therapy and Telix's differentiated, multi-product approach to treating pros...

2026-04-28 07:44 4028

Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia

Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs in transfusion-dependent aplastic anemia. HOUSTON, April 27, 2026 /PRNewswire/ -- Cellenkos®, Inc., a clinical-stage biotechnology company, developing allogeneic, tissue-targeted reg...

2026-04-27 23:19 4684

The EXCEL - First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease

PARIS, April 27, 2026 /PRNewswire/ -- A new study has established that treatment with essential phospholipids (Essentiale) resulted in a 2.5 times greater reduction in liver fat, significant improvement in fatigue and improvement of glycaemic control in individuals with Metabolic dysfunction–Ass...

2026-04-27 23:18 4812

CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026

LONDON, April 27, 2026 /PRNewswire/ -- Concept Medical Inc. , today announced the presentation of preliminary 3-year follow-up data from theSIRONA randomised trial at the Charing Cross (CX) Symposium 2026, reinforcing its leadership in drug-delivery technologies ...

2026-04-27 23:17 3720

Sarawak Secures Landmark Win to Host APAC's Leading Lung Disease Conference in 2028

KUCHING, Malaysia, April 27, 2026 /PRNewswire/ -- Sarawak has won hosting rights for the 11th Asia Pacific Regional Conference 2028 (APRC 2028) of the International Union Against Tuberculosis and Lung Disease, marking a significant milestone in the destination's continued rise as the legacy capit...

2026-04-27 22:11 3321

IMG Pharma Enters into Definitive Agreement to Acquire Matsumoto Pharmaceutical

TOKYO, April 27, 2026 /PRNewswire/ -- IMG Pharmaceutical Co., Ltd. ("IMG Pharma"), a majority-owned subsidiary of IMG Japan, the Group's holding company, announced that it has entered into a definitive agreement to acquire Matsumoto Pharmaceutical Co., Ltd., a Japanese pharmaceutical manufacturer...

2026-04-27 16:35 3422
12345678 ... 393

Week's Top Stories